Onconetix, Inc. — Director's Dealing 2022

Aug 23, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Blue Water Vaccines Inc. (BWV)
CIK: 0001782107
Period of Report: 2022-08-19

Reporting Person: Shaw Allan (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-08-19	Common Stock	F	29636	$0.01	Acquired	29636	Direct
2022-08-19	Common Stock	S	29636	$3.94	Disposed	0	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-08-19	Stock Option	$0.01	F	29636	Disposed	2030-01-14	Common Stock (29636)	Direct

Footnotes

F1: The Common Stock reported herein were sold by the reporting person at a high price of $4.02, a low price of $3.91 and an average price of $3.94 per share of Common Stock. Upon request, the reporting person will provide details of each sale.